Sunshine Biopharma Inc. short interest in 2024
In 2024, Sunshine Biopharma Inc.'s disclosed short interest ran from 0.44% of shares outstanding on 12 Jan 2024 to 10.90% on 31 Dec 2024, a change of +10.46 percentage points. The year's high was 27.79% on 29 Nov 2024 and its low 0.40% on 31 Jan 2024, averaging 8.91% across 9 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.60 days on 31 Dec 2024. Full history: Sunshine Biopharma Inc..
Cite this page
By year: 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 0.44% (12 Jan 2024)
- End of year
- 10.90% (31 Dec 2024)
- Change
- +10.46 pp
- High
- 27.79% (29 Nov 2024)
- Low
- 0.40% (31 Jan 2024)
- Average
- 8.91%
- Highest days to cover
- 1.60 (31 Dec 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 0.44% | 1.55 | |
| 31 Jan 2024 | 0.40% | 1.00 | |
| 31 May 2024 | 0.83% | 1.00 | 10-K filed, results (8-K), 10-Q filed, results (8-K) |
| 15 Jul 2024 | 1.90% | 1.00 | |
| 31 Jul 2024 | 2.49% | 1.00 | |
| 15 Nov 2024 | 11.70% | 1.30 | 10-Q filed, results (8-K), 10-Q filed, results (8-K) |
| 29 Nov 2024 | 27.79% | 1.00 | |
| 13 Dec 2024 | 23.72% | 1.00 | |
| 31 Dec 2024 | 10.90% | 1.60 |
See also: Sunshine Biopharma Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.